Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Sales | 17,920 | 21,640 | 39,400 | 28,530 | 19,140 |
| Cost of Goods | 17,640 | 22,430 | 36,710 | 28,530 | 12,910 |
| Gross Profit | 280 | -790 | 2,690 | 0 | 6,230 |
| Operating Expenses | 720 | 660 | 650 | 340 | 430 |
| Operating Income | -440 | -1,450 | 2,040 | -340 | 5,800 |
| Interest Expense | 0 | 0 | 0 | 30 | 150 |
| Other Income | -11,060 | -9,540 | -7,430 | 1,000 | -4,520 |
| Pre-tax Income | -11,500 | -10,990 | -5,390 | 630 | 1,130 |
| Income Tax | -1,560 | -1,850 | -1,530 | 310 | 430 |
| Net Income Continuous | -9,940 | -9,140 | -3,860 | 320 | 700 |
| Net Income | $-9,940 | $-9,140 | $-3,860 | $320 | $690 |
| EPS Basic Total Ops | -9.52 | -14.83 | -5.88 | 0.57 | N/A |
| EPS Basic Continuous Ops | -9.52 | -14.83 | -5.88 | 0.57 | N/A |
| EBITDA(a) | $-440 | $-1,450 | $2,040 | $-340 | $5,800 |